| pubmed-article:17384177 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17384177 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:17384177 | lifeskim:mentions | umls-concept:C0887899 | lld:lifeskim |
| pubmed-article:17384177 | lifeskim:mentions | umls-concept:C0017349 | lld:lifeskim |
| pubmed-article:17384177 | lifeskim:mentions | umls-concept:C0242656 | lld:lifeskim |
| pubmed-article:17384177 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:17384177 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:17384177 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:17384177 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17384177 | pubmed:dateCreated | 2007-5-28 | lld:pubmed |
| pubmed-article:17384177 | pubmed:abstractText | To investigate whether MHC class II expression on myeloid cells of patients with treatment-naive early rheumatoid arthritis (RA) correlates with disease progression. | lld:pubmed |
| pubmed-article:17384177 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17384177 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17384177 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17384177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17384177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17384177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17384177 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17384177 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17384177 | pubmed:issn | 1462-0324 | lld:pubmed |
| pubmed-article:17384177 | pubmed:author | pubmed-author:KaldenJ RJR | lld:pubmed |
| pubmed-article:17384177 | pubmed:author | pubmed-author:MuellerR BRB | lld:pubmed |
| pubmed-article:17384177 | pubmed:author | pubmed-author:WendlerJJ | lld:pubmed |
| pubmed-article:17384177 | pubmed:author | pubmed-author:Schulze-Koops... | lld:pubmed |
| pubmed-article:17384177 | pubmed:author | pubmed-author:SchuckAA | lld:pubmed |
| pubmed-article:17384177 | pubmed:author | pubmed-author:SkapenkoAA | lld:pubmed |
| pubmed-article:17384177 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17384177 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:17384177 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17384177 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17384177 | pubmed:pagination | 931-3 | lld:pubmed |
| pubmed-article:17384177 | pubmed:dateRevised | 2007-9-6 | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:meshHeading | pubmed-meshheading:17384177... | lld:pubmed |
| pubmed-article:17384177 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17384177 | pubmed:articleTitle | MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis. | lld:pubmed |
| pubmed-article:17384177 | pubmed:affiliation | Niklaus Fiebiger Center for Molecular Medicine, University of Erlangen-Nuremberg, Germany. | lld:pubmed |
| pubmed-article:17384177 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17384177 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
